Biomarkers
/
Inflammation
/
Platelet-to-Lymphocyte Ratio (PLR)

Platelet-to-Lymphocyte Ratio (PLR)

The Platelet-to-Lymphocyte Ratio (PLR) reflects thrombo-inflammatory burden and immune balance by combining platelet activity with adaptive immune status.
Subscribe for updates
By clicking “Subscribe” you agree to our Terms and Privacy Policy.
Your content is on its way!
By clicking “Subscribe” you agree to our TOS and Privacy Policy.
Oops! Something went wrong while submitting the form.
Book your test now
Book a Platelet-to-Lymphocyte Ratio (PLR) Test
With Superpower, you have access to a comprehensive range of biomarker tests
Physician reviewed
CLIA-certified labs
HIPAA compliant

Key benefits of Platelet-to-Lymphocyte Ratio testing

  • Flags hidden inflammation that standard tests may miss in chronic conditions.
  • Spots immune system imbalance linked to autoimmune disease or persistent infection.
  • Guides cardiovascular risk assessment when combined with lipid and metabolic panels.
  • Tracks treatment response in inflammatory bowel disease, rheumatoid arthritis, and lupus.
  • Clarifies unexplained fatigue by revealing low-grade systemic inflammation.
  • Supports cancer surveillance by detecting immune shifts during or after treatment.
  • Best interpreted alongside complete blood count and inflammatory markers like CRP.

What is Platelet-to-Lymphocyte Ratio?

The platelet-to-lymphocyte ratio (PLR) is a calculated marker that compares the number of platelets to the number of lymphocytes in your blood. Platelets are tiny cell fragments made in your bone marrow that help form clots and stop bleeding. Lymphocytes are a type of white blood cell that coordinate your immune response against infections and abnormal cells.

A window into inflammation and immune balance

PLR reflects the balance between two opposing forces: clotting and inflammation (driven by platelets) versus immune regulation and defense (driven by lymphocytes). When this ratio shifts, it often signals that your body is responding to stress, infection, chronic inflammation, or immune dysregulation.

Why doctors track this simple calculation

Because PLR combines information from two different cell types, it captures a broader picture of your body's inflammatory and immune state than either measurement alone. It has emerged as a useful marker in cardiovascular disease, cancer, autoimmune conditions, and metabolic disorders, where the interplay between clotting tendency and immune function plays a central role.

Why is Platelet-to-Lymphocyte Ratio important?

The platelet-to-lymphocyte ratio (PLR) reflects the balance between clotting activity and immune regulation, offering a window into inflammation, immune health, and cardiovascular risk. Typical values range from 100 to 300, with optimal levels generally sitting in the lower half of that range. When this ratio shifts, it signals changes in how your body manages injury repair, infection defense, and chronic inflammatory stress.

When the ratio drops below normal

A low PLR usually means lymphocytes are elevated relative to platelets, often seen during active viral infections, autoimmune flares, or bone marrow disorders. This pattern suggests your immune system is highly activated or that platelet production is suppressed. You may feel fatigued, bruise easily, or notice swollen lymph nodes as your body redirects resources toward immune defense.

When the ratio climbs too high

An elevated PLR points to increased platelets, reduced lymphocytes, or both, commonly linked to chronic inflammation, cardiovascular disease, metabolic syndrome, and certain cancers. This imbalance can reflect smoldering arterial stress, insulin resistance, or immune exhaustion. Over time, it may contribute to clot formation, heart attack risk, and poor surgical or cancer outcomes.

The bigger inflammatory picture

PLR integrates signals from your bone marrow, immune system, and vascular health, making it a useful marker for tracking systemic inflammation and disease progression. It complements other inflammatory indices and helps clinicians assess long-term risk for thrombosis, metabolic disease, and immune dysfunction.

What do my Platelet-to-Lymphocyte Ratio results mean?

Low platelet-to-lymphocyte ratio

Low values usually reflect either reduced platelet production or elevated lymphocyte counts. This pattern can appear during viral infections when lymphocytes expand, in certain autoimmune conditions, or with bone marrow disorders that suppress platelet formation. It may also occur in chronic lymphocytic leukemia or after chemotherapy. A low ratio generally suggests less systemic inflammation but warrants investigation if persistent.

Optimal platelet-to-lymphocyte ratio

Being in range suggests balanced immune surveillance and normal platelet turnover. Most labs consider a ratio below 150 to 180 as normal, though optimal values typically sit in the lower half of this range. A stable ratio reflects appropriate coordination between clotting and immune systems, with neither excessive inflammation nor immune suppression.

High platelet-to-lymphocyte ratio

High values usually reflect increased systemic inflammation, elevated platelet production, or reduced lymphocyte counts. This pattern is common in chronic inflammatory states, active infections, cardiovascular disease, and many cancers. It can also appear with stress, smoking, metabolic syndrome, or after surgery. Elevated ratios correlate with worse outcomes in cardiovascular events and malignancies, serving as a marker of inflammatory burden rather than a specific diagnosis.

Factors that influence platelet-to-lymphocyte ratio

This ratio varies with acute illness, recent infection, medications that affect platelets or white cells, and physiologic stress. Pregnancy, older age, and chronic conditions all shift baseline values. Interpretation requires clinical context and trending over time.

PLR is calculated by dividing platelet count by lymphocyte count from a complete blood count. Platelets reflect clotting and inflammatory drive, while lymphocytes represent adaptive immune defense.
A higher PLR suggests more platelet-driven or pro-inflammatory activity; a lower PLR suggests stronger immune balance or fewer platelets.

Do I need a Platelet-to-Lymphocyte Ratio test?

Struggling with chronic inflammation, unexplained fatigue, or concerns about your immune health? Could your Platelet-to-Lymphocyte Ratio reveal hidden inflammation that's affecting how you feel?

Your PLR measures the balance between platelets and lymphocytes in your blood. This simple ratio helps identify underlying inflammation and immune system stress that standard tests might miss.

Testing your PLR gives you a quick snapshot of your inflammatory state, empowering you to address the root causes of fatigue and immune concerns with targeted lifestyle changes and personalized health strategies.

Get tested with Superpower

If you’ve been postponing blood testing for years or feel frustrated by doctor appointments and limited lab panels, you are not alone. Standard healthcare is often reactive, focusing on testing only after symptoms appear or leaving patients in the dark.

Superpower flips that approach. We give you full insight into your body with over 100 biomarkers, personalized action plans, long-term tracking, and answers to your questions, so you can stay ahead of any health issues.

With on-demand access to a care team, CLIA-certified labs, and the option for at-home blood draws, Superpower is designed for people who want clarity, convenience, and real accountability - all in one place.

Method: Derived from FDA-cleared laboratory results. This ratio/index is not an FDA-cleared test. It aids clinician-directed risk assessment and monitoring and is not a stand-alone diagnosis. Inputs: platelets, lymphocytes.

Subscribe for updates
By clicking “Subscribe” you agree to our Terms and Privacy Policy.
Your content is on its way!
By clicking “Subscribe” you agree to our TOS and Privacy Policy.
Oops! Something went wrong while submitting the form.

Similar biomarker tests from Superpower

See more biomarkers

FAQs about Platelet-to-Lymphocyte Ratio (PLR)

Platelet-to-lymphocyte ratio (PLR) is a calculated marker from a standard complete blood count (CBC). It’s found by dividing your platelet count (cells involved in clotting) by your lymphocyte count (immune white blood cells) from the same blood sample. Because platelets often rise and lymphocytes may fall during inflammation, PLR provides a simple snapshot of systemic inflammation and immune balance.

Clinicians track PLR because it reflects the balance between clotting activity (platelets) and immune surveillance (lymphocytes). Inflammation can push platelet counts up while lowering lymphocytes, increasing the ratio. This makes PLR a helpful, low-cost way to gauge systemic inflammation, immune regulation, and stress responses across many conditions, especially when interpreted alongside symptoms and other lab markers.

Normal PLR values are typically about 100 to 300, although reference ranges can vary by laboratory. “Optimal” health often sits in the lower half of that range, which may reflect lower background inflammation and stable immune function. PLR is not diagnostic on its own, so the most meaningful interpretation considers your absolute platelet and lymphocyte counts and your overall clinical picture.

A high PLR - often above 200 or 300 - suggests platelets are rising faster than lymphocytes, which commonly happens in chronic inflammation. This pattern is associated with metabolic syndrome, cardiovascular disease, and increased clot risk, and it correlates with poorer outcomes in heart disease and stroke. Persistent elevation may indicate smoldering inflammation that can damage blood vessels and promote atherosclerosis.

A PLR below 100 usually means lymphocytes are elevated relative to platelets. This can occur during active viral infections, autoimmune flares, or bone marrow disorders that suppress platelet production. Some hematologic diseases can also affect either cell line and lower the ratio. If platelets are truly low, people may notice symptoms like fatigue or easy bruising.

PLR can add “immune context” when symptoms are vague or persistent. Unexplained fatigue, joint pain, or recurrent infections may relate to inflammation or immune imbalance that a basic review might miss. A higher PLR may point toward chronic inflammatory stress, while a lower PLR may align with viral activity or altered blood cell production. It’s most useful when combined with CBC details and clinical evaluation.

PLR can help track systemic inflammation and immune shifts over time, which is why clinicians may use it to follow autoimmune or inflammatory disease activity. Trending PLR before and after treatment can support decisions about whether anti-inflammatory or biologic therapies are reducing inflammatory burden. Because PLR can change for many reasons, it should be interpreted alongside symptoms, absolute counts, and other inflammation markers.

In cancer, PLR can track inflammatory burden and disease progression. Elevated PLR is seen in certain malignancies and may correlate with prognosis or treatment effectiveness because chronic inflammation can raise platelets and suppress lymphocytes. Clinicians may follow PLR trends during therapy as part of a broader assessment, rather than relying on it alone, to understand how the body’s immune and clotting systems are responding.

PLR is a derived ratio, so it can be misleading without the underlying numbers and related inflammation markers. Pairing PLR with CRP and ESR helps confirm whether inflammation is present and how intense it is, while the CBC shows whether platelets or lymphocytes are driving the change. This combined view provides a fuller picture of systemic inflammation, immune health, and potential vascular or metabolic risk.

PLR can shift with acute illness, infection, surgery, pregnancy, and medications that affect platelet or lymphocyte counts. For example, inflammation or tissue injury can raise platelets, while prolonged stress or severe illness may lower lymphocytes - both increasing PLR. Because these influences can be temporary, a single result shouldn’t be overinterpreted; trends over time and the clinical context matter most.